# Celldex Therapeutics, Inc.: Form 8-K, filed Nov 5, 2020

- Company: [Celldex Therapeutics, Inc.](/companies/cldx.md) (CIK 744218)
- Form: 8-K
- Filed: 2020-11-05
- Accepted by EDGAR: Nov 5, 2020, 16:01 ET
- Period: 2020-11-05
- Accession: 0001171843-20-007664
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/744218/000117184320007664/f8k_110520.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/744218/000117184320007664/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/744218/000117184320007664/f8k_110520.htm

Filed Nov 5, 2020.
Source: SEC EDGAR, the filing index for accession 0001171843-20-007664. Last ingested by Listed: Nov 5, 2026, 19:04 ET. No prices; not investment advice.
